Found 5 results

Name Type of Offering Accepted Date
Lysosomal Therapeutics, Inc. See All Filings
D 2014-05-13
Amount To Be Raised $4,842,033
Associated Brokers / Dealers N/A
CIK Number 0001607854
Filed Document 0001607854-14-000001
Exclusions or Exemptions 506b
Accepted Date 2014-05-13
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lysosomal Therapeutics, Inc. See All Filings
D 2016-10-06 16:53:16
Amount To Be Raised $6,000,000
Associated Brokers / Dealers N/A
CIK Number 0001607854
Filed Document 0001607854-16-000003
Exclusions or Exemptions 506b
Accepted Date 2016-10-06 16:53:16
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt
Lysosomal Therapeutics, Inc. See All Filings
D/A 2017-01-18 11:55:49
Amount To Be Raised $26,124,936
Associated Brokers / Dealers N/A
CIK Number 0001607854
Filed Document 0001607854-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-01-18 11:55:49
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lysosomal Therapeutics, Inc. See All Filings
D 2015-02-05
Amount To Be Raised $20,000,004
Associated Brokers / Dealers N/A
CIK Number 0001607854
Filed Document 0001607854-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-02-05
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Lysosomal Therapeutics, Inc. See All Filings
D 2019-11-07 17:26:03
Amount To Be Raised $3,000,000
Associated Brokers / Dealers N/A
CIK Number 0001607854
Filed Document 0001607854-19-000001
Exclusions or Exemptions 506b
Accepted Date 2019-11-07 17:26:03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Debt